Association of metabolic‐associated fatty liver disease and risk of severe coronavirus disease 2019 illness
Abstract Given the global health burden caused by the Coronavirus Disease 2019 (COVID‐19), there have been numerous studies aimed to understand its clinical course and to determine risk factors that may impact prognosis. Pre‐existing medical conditions are linked with COVID‐19 severity, particularly...
Main Authors: | Marianne Linley Sy‐Janairo, Ian Homer Y Cua |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | JGH Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/jgh3.12465 |
Similar Items
-
Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
by: Yanlan Xu, et al.
Published: (2021-10-01) -
Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis
by: Péter Jenő Hegyi, et al.
Published: (2021-03-01) -
Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis
by: Guohong-Liu, et al.
Published: (2019-11-01) -
Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis
by: A. L. Han
Published: (2021-05-01) -
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)